跳至主要内容
临床试验/ACTRN12617000487314
ACTRN12617000487314进行中(未招募)2 期

A double-blind randomized sham-controlled trial to evaluate the effect of prefrontal Theta Burst Stimulation on severity and impact of pain in patients with fibromyalgia

Dr Bernadette Fitzgibbon0 个研究点目标入组 40 人开始时间: 2017年4月4日最近更新:
适应症

试验速览

阶段
2 期
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • Inclusion Criteria: patients will be included if they:
  • - have a current diagnosis of fibromyalgia
  • - aged between 18 and 75 years
  • - have had no increase or initiation of new medication therapy in the four weeks prior to study screen

排除标准

  • Exclusion Criteria: Participants who:
  • - Patients who have an unstable medical condition, neurological disorder or any history of seizure disorder or are currently pregnant or lactating
  • - The presence of metal anywhere in the head, except the mouth, which may interfere with the magnetic field
  • - Have a current DSM-V diagnosis of Substance Abuse or Dependence disorder, or another psychiatric condition. This excludes depression, PTSD or anxiety unless they are the primary disorder (i.e. fibromyalgia is not the primary disorder).

研究者

发起方
Dr Bernadette Fitzgibbon

相似试验